Delcath Systems, Inc. (NASDAQ:DCTH - Get Free Report) fell 4.4% during mid-day trading on Friday . The company traded as low as $16.30 and last traded at $16.31. 32,233 shares changed hands during trading, a decline of 91% from the average session volume of 375,346 shares. The stock had previously closed at $17.06.
Analyst Ratings Changes
A number of brokerages have issued reports on DCTH. HC Wainwright reaffirmed a "buy" rating and set a $29.00 price target (up from $24.00) on shares of Delcath Systems in a report on Friday, May 23rd. Wall Street Zen downgraded Delcath Systems from a "strong-buy" rating to a "buy" rating in a report on Sunday. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $24.00.
Read Our Latest Report on DCTH
Delcath Systems Trading Down 5.8%
The firm has a market capitalization of $559.65 million, a PE ratio of -11.90 and a beta of 0.72. The company has a fifty day moving average price of $13.30 and a two-hundred day moving average price of $13.22.
Delcath Systems (NASDAQ:DCTH - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.07). Delcath Systems had a negative net margin of 150.70% and a negative return on equity of 338.16%. The firm had revenue of $19.80 million during the quarter, compared to analysts' expectations of $16.83 million. As a group, equities research analysts predict that Delcath Systems, Inc. will post -0.79 earnings per share for the current year.
Institutional Trading of Delcath Systems
Several institutional investors and hedge funds have recently made changes to their positions in DCTH. Soleus Capital Management L.P. purchased a new stake in Delcath Systems during the 4th quarter valued at approximately $9,644,000. Vivo Capital LLC raised its stake in Delcath Systems by 71.4% during the 4th quarter. Vivo Capital LLC now owns 1,708,579 shares of the company's stock valued at $20,571,000 after acquiring an additional 711,574 shares during the last quarter. Gilder Gagnon Howe & Co. LLC purchased a new stake in Delcath Systems during the 4th quarter valued at approximately $7,371,000. Invesco Ltd. purchased a new stake in Delcath Systems during the 1st quarter valued at approximately $5,084,000. Finally, Vanguard Group Inc. raised its stake in Delcath Systems by 13.8% during the 1st quarter. Vanguard Group Inc. now owns 1,394,028 shares of the company's stock valued at $17,746,000 after acquiring an additional 169,260 shares during the last quarter. 61.12% of the stock is owned by hedge funds and other institutional investors.
About Delcath Systems
(
Get Free Report)
Delcath Systems, Inc, an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Further Reading
Before you consider Delcath Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delcath Systems wasn't on the list.
While Delcath Systems currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
